 |
 |
 |
|
HEPATITIS C CASCADE OF CARE IN A MULTIDISCIPLINARY
SUBSTANCE USE BRIDGE CLINIC MODEL
|
|
|
ID Week 2022 Oct 19-22
ANA SIMONYAN, PHARMD, BCACP1; SAMANTHA CHIRUNOMULA, MD4; KRISTEN WHELCHEL, PHARMD, CSP1; FIONA GISPEN, MD5, MS; DAVID MARCOVITZ, MD3 KATIE D. WHITE, MD2, PHD; CODY A. CHASTAIN, MD2
1VANDERBILT SPECIALTY PHARMACY; 2DIVISION OF INFECTIOUS DISEASE, VANDERBILT UNIVERSITY MEDICAL CENTER; 3DIVISION OF PSYCHIATRY, VANDERBILT UNIVERSITY MEDICAL CENTER; 4 DEPARTMENT OF PSYCHIATRY, UNIVERSITY OF ILLINOIS AT CHICAGO; 5DIVISION OF INFECTIOUS DISEASE, CORNELL MEDICAL CENTER



|
|
|
 |
 |
|
|